Homepage

Unlock their full potential

15 years of biosimilars

Our Purpose and Ambition

We are a global leader in generic and biosimilar pharmaceuticals, committed to driving access to medicine

Sandoz officially certified as Global Top Employer 2021

COVID-19 Information Center

The information center provides a central hub for news, guidance and resources.

Explore Novartis

About Us

Who We Are

Our Work

What We Do

About Us

Corporate Responsibility

Careers

Job Search

Recent Updates

Featured / Jul 21

Novartis Financial Results – Q2 2021

Novartis announced the company’s financial results for the second quarter and first half of 2021.

Listening to Patient Perspectives: Richard Saynor In Conversation with Patient Advocacy Leaders

International Day of the African Child

June 16 marks The International Day of the African Child.

Ushering in the next wave of biosimilars by unlocking their potential

Media Release / May 17

US Supreme Court denies Sandoz petition to review biosimilar Erelzi® (etanercept-szzs) case

View All

RT @cancereu: "#COVID19 is the greatest challenge of our time. But we are not powerless. We must preserve and confront this crisi… https://t.co/RzWgK3CB3q 4 days 5 hours ago

Our Work

At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine.

Learn More